WELLS FARGO & COMPANY/MN - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 24 filers reported holding ELIEM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118
-6.3%
450.0%0.00%
Q2 2023$126
+3.3%
45
+7.1%
0.00%
Q1 2023$122
-20.8%
420.0%0.00%
Q4 2022$15442
+2.4%
0.00%
Q3 2022$041
-6.8%
0.00%
Q2 2022$0
-100.0%
44
-98.8%
0.00%
Q1 2022$31,000
-53.7%
3,718
-42.1%
0.00%
Q4 2021$67,000
+6600.0%
6,424
+20622.6%
0.00%
Q3 2021$1,000310.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,658,170$4,808,6934.16%
RA Capital Management 13,150,849$38,137,4620.86%
SILVERARC CAPITAL MANAGEMENT, LLC 485,955$1,409,2700.58%
Atom Investors LP 78,886$228,7690.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 673,684$1,953,6840.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$160,1470.00%
Chicago Partners Investment Group LLC 18,520$52,4120.00%
TUDOR INVESTMENT CORP ET AL 29,706$860.00%
NORTHERN TRUST CORP 11,247$32,6160.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ELIEM THERAPEUTICS INC shareholders